98%
921
2 minutes
20
Background: Non-adherence to clinic visits among patients with severe mental illness (SMI) presents challenges to patient management, treatment outcomes, and research in resource-limited settings. This study investigated the factors associated with non-adherence to clinic visits in Uganda, using appointment attendance as a proxy for clinic adherence.
Methods: This cohort study took place at Butabika National Referral Mental Hospital and Masaka Regional Referral Hospital from January to March 2018. A total of 1,201 participants with confirmed diagnoses of SMI were systematically sampled from over 3,000 outpatients. Data on socio-demographic, psychosocial, psychiatric, and behavioural factors were collected, with adherence defined as attending scheduled visits at 3, 6, 9, and 12 months post-enrolment. Descriptive statistics, bivariate, and multivariate logistic regression analyses were employed to identify significant predictors of non-adherence.
Results: The overall prevalence of non-adherence to clinic visits was 20% (95% CI: 17.8 − 22.3%), with males showing higher rates (22.9%) compared to females (17.6%). Factors significantly associated with increased non-adherence included younger age, being treated at Butabika National Referral Mental Hospital, and alcohol use. Conversely, higher social support was linked to improved adherence. Among psychiatric variables, patients with major depressive disorder and severe psychiatric symptoms were more likely to miss appointments.
Conclusions: The study highlights the multifaceted nature of non-adherence in patients with SMI, emphasizing the need for targeted interventions addressing socio-demographic, psychosocial, and clinical factors. Enhancing social support, managing psychiatric symptoms, and reducing substance use are critical strategies for improving adherence rates, which could, in turn, lead to better health outcomes and resource optimization in mental health services.
Supplementary Information: The online version contains supplementary material available at 10.1186/s12888-025-07121-7.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308915 | PMC |
http://dx.doi.org/10.1186/s12888-025-07121-7 | DOI Listing |
PLOS Glob Public Health
September 2025
Center for Tuberculosis, Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, United States of America.
Multi-month dispensing of tuberculosis (TB) drugs is an innovative strategy that may reduce frequent clinic visits and travel costs among people with TB (PWTB) in rural areas. To inform a planned trial, we explored the appropriateness, barriers, and facilitators to multi-month dispensing among PWTB and healthcare providers in rural eastern Uganda. We used qualitative methods situated within the Consolidated Framework for Implementation Research to explore two refill schedules for multi-month dispensing of TB drugs-a four- or five-visit refill schedule.
View Article and Find Full Text PDFBr J Cancer
September 2025
Department of Pharmacy, the First Affiliated Hospital of Ningbo University, Zhejiang, China.
Background: Adherence to imatinib may be even more limited in the adjuvant setting, as patients receiving adjuvant imatinib often do not experience disease symptoms after tumor removal. This real-world study aimed to gain insight into adherence to imatinib and the effect of adherence on treatment outcomes.
Methods: Postoperative GIST patients who visited the speciality clinic between January 2021 and September 2024 were included in the study.
Phlebology
September 2025
Emeritus Professor of Venous Surgery, Rotterdam, Netherlands.
BackgroundCompression therapy (CT) is widely prescribed for chronic venous disease (CVD), lymphedema, and lipedema despite robust evidence supporting its effectiveness only in a minority of clinical scenarios.AimProvide an overview of the methodological parameters essential for obtaining a high-quality scientific trial.MethodsThe International Compression Club (ICC) chairman prepared a preliminary list of the main methodological flaws in publications on CT, and a list of parameters to be included in high-quality randomized controlled trials (RCTs).
View Article and Find Full Text PDFMatern Health Neonatol Perinatol
September 2025
Department of Obstetrics and Gynaecology College of Medicine and Health Science, School of Medicine, Debre Berhan University, Debre Berhan, Ethiopia.
Background: Non-adherence to antiretroviral therapy (ART) among pregnant women poses significant challenges to effective Immunodeficiency Virus (HIV) treatment outcomes and the promotion of maternal and infant health. This study identifies factors influencing ART non-adherence among HIV-positive pregnant women attending public health facilities in Dessie Town, Ethiopia.
Methods: A facility-based case-control study was conducted with 278 participants across health institutions in Dessie Town, comprising 208 controls and 70 cases.
Front Pharmacol
August 2025
Department of Cardiology, Hacettepe University Medical Faculty, Ankara, Türkiye.
Introduction: Medication non-adherence (NA) remains a persistent challenge across all medical specialties, contributing to adverse patient outcomes and increased healthcare burdens. While numerous studies have explored patient-related factors influencing adherence, the perspectives of healthcare professionals remain underrepresented in literature. This study aims to document the individual experiences of seven international physicians across diverse medical fields, highlighting barriers, detection methods, and strategies employed to address NA in their daily practice.
View Article and Find Full Text PDF